--- title: "Weekly Recap | Vnet +3%, consensus target above spot" type: "News" locale: "en" url: "https://longbridge.com/en/news/299515481.md" description: "Vnet added 3% this week to close at $6.52, while the S&P 500 slipped 0.08%, leaving the stock about 3.08 percentage points ahead of the benchmark. The week started quietly: shares traded between $5.91 and $6.253 from Monday to Wednesday and sat near $6.09 on Thursday. Friday brought a high-volume push to $6.56, and the stock closed near the top of its weekly range." datetime: "2026-09-19T06:59:18.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/299515481.md) - [en](https://longbridge.com/en/news/299515481.md) - [zh-HK](https://longbridge.com/zh-HK/news/299515481.md) generator: "portal-rs" --- # Weekly Recap | Vnet +3%, consensus target above spot ## The Week Vnet added 3% this week to close at $6.52, while the S&P 500 slipped 0.08%, leaving the stock about 3.08 percentage points ahead of the benchmark. The week started quietly: shares traded between $5.91 and $6.253 from Monday to Wednesday and sat near $6.09 on Thursday. Friday brought a high-volume push to $6.56, and the stock closed near the top of its weekly range. ## Key Events The company did not release standalone earnings or deal news this week. Instead, the story centred on its data-centre sector. Several Tuesday articles tied computing power networks, data centres and industrial mobility together against a backdrop of AI infrastructure demand and global macro fragmentation, with Vnet included as an independent data-centre operator. After Friday’s rally, weekend market round-ups noted the stock’s 7.5% gain on the day and linked it to the broader computing infrastructure theme. On balance, the week looked more like sector-level attention flowing through than a company-specific catalyst. ## Analyst Ratings Of the 14 firms covering Vnet, 9 rate it buy, 4 rate it overweight, 1 rates it underweight, and none have a hold or sell rating. The consensus rating is buy, with a consensus target price of $13.62, about 108.9% above the latest close of $6.52. Target prices range from $7.587 to $25.125, a wide spread that reflects divergent views. Within the cloud and data-centre industry, the stock ranks 13th out of 30 names by rating. ## The Week Ahead A run of US macro data lands next week: the Richmond Fed composite index on Tuesday, EIA crude and Cushing inventory reports on Wednesday, and initial jobless claims, current account balance, new home sales and natural gas storage on Thursday. Data centres are sensitive to rates and risk appetite, so these releases could feed into sentiment around the stock. ## In Short The week’s upward move coincided with rising attention on infrastructure names, but average daily volume was about 10.6% below its 60-day median. The latest session showed large-lot money as a net seller, while the consensus target price sits well above spot. The stock is back above its 20-day moving average but still below the 60-day line, and with the company loss-making, valuation is better framed by price-to-book at roughly 3.09x. The question ahead is whether the high-volume push can hold, and how the gap between analyst targets and the actual price narrows. *This article is generated by LongbridgeAI from market data, for information only and not investment advice.* ### Related Stocks - [VNET.US](https://longbridge.com/en/quote/VNET.US.md) ## Related News & Research - [VNET Group (NASDAQ:VNET) Announces Earnings Results, Misses Expectations By $0.02 EPS](https://longbridge.com/en/news/296220797.md) - [VNET Group (VNET) Expected to Release Earnings on Tuesday](https://longbridge.com/en/news/295520859.md) - [Corient Private Wealth LP Has $4.29 Million Stock Position in MACOM Technology Solutions Holdings, Inc. $MTSI](https://longbridge.com/en/news/299545996.md) - [KLA (KLAC) Could Be 24% Undervalued On AI Demand And Backlog Growth](https://longbridge.com/en/news/299544182.md) - [How Investors May Respond To Omega Healthcare Investors Stock Higher Rate Pressure](https://longbridge.com/en/news/299531807.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**